Kanghua Biological: Controlling shareholder intends to change to Wan Ke Xin Biotechnology, stock will resume trading.

Kanghua Biology announced on the evening of July 20 that the controlling shareholder and actual controller of the company, Wang Zhentao, along with his concerted action party Oconn Group and shareholder Kang Yueqiming, intend to transfer a total of 28.4666 million shares held by the company to Shanghai Wan Kexin Biotechnology Partnership Enterprise, accounting for 21.91% of the total share capital after excluding the company's repurchased shares. The transfer price is approximately RMB 65.03 per share, totaling RMB 1.851 billion. After the transfer of the above-mentioned shares, Wang Zhentao will entrust the voting rights, nomination rights, and proposal rights of the remaining 8.08% shares he holds in the company to Wan Kexin Biological for exercise. After the implementation, Wan Kexin Biotechnology will have a voting power of 29.99% in the company, and the controlling shareholder of the company will change from Wang Zhentao to Wan Kexin Biotechnology. Since Wan Kexin Biotechnology has no actual controller, the actual controller of the company will change from Wang Zhentao to no actual controller. The company's stock will resume trading on July 21.